Therapy Areas: Cardiovascular
21 February 2024 - Hyperfine Inc (Nasdaq: HYPR), a provider of diagnostic imaging solutions, announced on Wednesday that it is collaborating with Athletic Heart Cardiac and Metabolic Testing, LLC (Ath...
21 February 2024 - Clinical infrastructure specialist Feedback plc (AIM: FDBK) announced on Wednesday that it has entered into a partnership with radiology specialist Medical Imaging Partnership (MIP)...
16 February 2024 - Ionis Pharmaceuticals, Inc. (Nasdaq: IONS), a United States-based biotechnology company, announced on Thursday that it has received Orphan Drug designation from the US Food and Drug...
13 February 2024 - Biotechnology company Rocket Pharmaceuticals (RCKT:NASDAQ) announced on Tuesday an extension of the Priority Review period by the US FDA for KRESLADI, an investigational gene therap...
12 February 2024 - CSL (ASX:CSL; USOTC:CSLLY), a global biotechnology company, announced on Sunday the top-line outcome from its Phase three AEGIS-II trial assessing the efficacy and safety of CSL112 ...
8 February 2024 - Biotechnology company Ionis Pharmaceuticals Inc (Nasdaq:IONS) announced on Thursday that the US Food and Drug Administration (FDA) has granted Fast Track designation to eplontersen, ...